CFO of Antigenics Inc. (AGEN, Financial) Shalini Sharp sells 1,500 shares of AGEN on 10/28/2010 at an average price of $0.96 a share.
Antigenics Inc. has a market cap of $93.1 million; its shares were traded at around $0.96 with and P/S ratio of 27.9.
Antigenics Inc. has a market cap of $93.1 million; its shares were traded at around $0.96 with and P/S ratio of 27.9.
CFO Recent Trades:
- Sell: CFO Shalini Sharp sold 2,000 shares of AGEN stock on 09/14/2010 at the average price of 0.91. Shalini Sharp owns at least 244,098 shares after this. The price of the stock has increased by 5.49% since.
- Sell: CFO Shalini Sharp sold 1,520 shares of AGEN stock on 07/27/2010 at the average price of 0.93. Shalini Sharp owns at least 241,098 shares after this. The price of the stock has increased by 3.23% since.
Directors and Officers Recent Trades:
- Buy: Director Timothy Wright bought 10,000 shares of AGEN stock on 05/18/2010 at the average price of 1.34. Timothy Wright owns at least 10,000 shares after this. The price of the stock has decreased by 28.36% since.
- Sell: Vp, Clin, Reg & Quality Kerry Wentworth sold 1,453 shares of AGEN stock on 09/14/2010 at the average price of 0.91. Kerry Wentworth owns at least 144,088 shares after this. The price of the stock has increased by 5.49% since.
- Sell: VP and General Counsel Karen Valentine sold 3,333 shares of AGEN stock on 09/14/2010 at the average price of 0.91. Karen Valentine owns at least 56,491 shares after this. The price of the stock has increased by 5.49% since.
- Sell: VP, Finance Christine M Klaskin sold 1,365 shares of AGEN stock on 09/14/2010 at the average price of 0.91. Christine M Klaskin owns at least 71,651 shares after this. The price of the stock has increased by 5.49% since.
- Sell: VP, Clin, Reg & Quality Kerry Wentworth sold 4,165 shares of AGEN stock on 07/26/2010 at the average price of 0.8. Kerry Wentworth owns at least 140,541 shares after this. The price of the stock has increased by 20% since.
